FAKTOR-OPTIONSSCHEIN - INMODE Stock

Certificat

DE000MD0YM67

Market Closed - Börse Stuttgart 15:27:01 2024-05-31 EDT
0.36 EUR -.--% Intraday chart for FAKTOR-OPTIONSSCHEIN - INMODE
Current month+20.00%
1 month+20.00%
Date Price Change
24-05-31 0.36 -.--%
24-05-30 0.36 -.--%
24-05-29 0.36 +5.88%
24-05-28 0.34 -.--%
24-05-27 0.34 -.--%

Delayed Quote Börse Stuttgart

Last update May 31, 2024 at 03:27 pm

More quotes

Static data

Product typeExotische Produkte
Buy / SellCALL
Underlying INMODE LTD.
Issuer Morgan Stanley
WKN MD0YM6
ISINDE000MD0YM67
Date issued 2022-01-06
Strike 9.437 $
Maturity Unlimited
Parity 24.41 : 1
Emission price 10
Emission volume N/A
Settlement Barausgleich
Currency EUR

Technical Indicators

Highest since issue 8.95
Lowest since issue 0.29
Spread 0.01
Spread %2.70%

Company Profile

Inmode Ltd is an Israel-based global provider of energy-based, minimally-invasive surgical medical treatment solutions. Company's products and solutions are primarily designed to address three energy-based treatment categories comprised of: face and body contouring; medical aesthetics; and women’s health. The Company have developed and commercialized products utilizing medically-accepted RF energy technology, which can penetrate deep into the subdermal fat, allowing adipose tissue remodeling. It's RF energy-based proprietary technologies - Radio Frequency Assisted Lipolysis (RFAL), Deep Subdermal Fractional RF, Simultaneous Fat Destruction and Skin Tightening and Deep Heating Collagen Remodeling for skin and human natural openings- represent a paradigm shift in the minimally-invasive aesthetic solutions market. These technologies are used by physicians to remodel subdermal adipose, or fatty tissue in a variety of procedures.
Sector
-
More about the company

Ratings for InMode Ltd.

Trading Rating
Investor Rating
ESG Refinitiv
More Ratings

Consensus: InMode Ltd.

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
6
Last Close Price
19.13 USD
Average target price
25.6 USD
Spread / Average Target
+33.82%
Consensus